Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by nopoo2on Dec 08, 2014 11:54am
368 Views
Post# 23206243

From Philip

From PhilipHi Rick

Sernova's has developed the Cell Pouch(tm) as a scalable, biocompatible, implantable device which forms vascularized tissue chambers to create a natural environment for therapeutic cells.

These therapeutic cells may be human donor cells whose supply is very limited or come from an unlimited source of cells such as stem cells or porcine cells. We are very encouraged by the recent advances in insulin producing stem cell technologies.

Sernova's unique approach is to protect these cells on a micro level within the Cell Pouch(tm) to enable the required blood vessels to grow into or come very close to the cells. We have over 5 years experience developing, contract manufacturing and testing the Cell Pouch (tm) in animal models and now in humans.

In this field, we firmly believe the smartest way to proceed is to engage in academic and corporate partnerships to combine the best technologies,  which is why we put together an elite business development team.

This is a very exciting time for regenerative medicine, for cell therapies and for Sernova. The fact that others are now interested in this field shows that Sernova has been on the right path for the past 5 years.

Best regards,

Philip

Bullboard Posts